Results 61 to 70 of about 1,518,675 (340)

FACTORS CONTRIBUTING TO LOW RESPONSE TOWARDS COVID-19 VACCINATION AMONG RESIDENTS OF ACOO VILLAGE, KOLE DISTRICT. A CROSS-SECTIONAL DESCRIPTIVE STUDY.

Student's Journal of Health Research Africa, 2023
Background: The main purpose of the study was to determine the factors contributing to low response towards COVID-19 vaccination among residents of Acoo village, Kole district.
Monica Amolo , Richard Kanyesigye
doaj   +1 more source

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Human Vaccines & Immunotherapeutics, 2020
Background The development of a vaccine against SARS-CoV-2 infection is on the way. To prepare for public availability, the acceptability of a hypothetical COVID-19 vaccine and willingness to pay (WTP) were assessed to provide insights into future demand
L. Wong, Haridah Alias, P. Wong, Hai-Yen Lee, S. Abubakar   +4 more
semanticscholar   +1 more source

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

Lancet Public Health, 2021
Background Opinion polls on vaccination intentions suggest that COVID-19 vaccine hesitancy is increasing worldwide; however, the usefulness of opinion polls to prepare mass vaccination campaigns for specific new vaccines and to estimate acceptance in a ...
M. Schwarzinger, V. Watson, P. Arwidson, F. Alla, S. Luchini   +4 more
semanticscholar   +1 more source

COVID-19 vaccination passports [PDF]

Science, 2021
As countries grow eager to reignite their economies and people increasingly yearn for mobility and normalcy in life, pressure is mounting for some form of COVID-19 health status certificate that would support these desires. There has already been an explosion of COVID-19 passport initiatives for domestic use and international travel.
Dye, C, Mills, MC
openaire   +2 more sources

Nanomedicine and the COVID-19 vaccines [PDF]

Nature Nanotechnology, 2020
Two nanoparticle-based vaccines close to obtaining approval by the US Food and Drug Administration could represent a giant step in the fight against the COVID-19 pandemic.
openaire   +2 more sources

Public COVID-19 vaccination acceptance: A narrative review of correlated factors

, 2022
 Following the discovery of the first instances of COVID-19 in nations and the subsequent announcement of a “pandemic” by WHO, worldwide efforts to identify efficient methods to combat COVID-19 began.
Mohammadjavad Nourmohammadi (13816786), Yarahmadi, Amir Hossein, Kakavand, Peyman, Nasrollahi, Amir Hossein, Amirali Hatami (13816774), Asadi, Heshmatollah, Peyman Kakavand (13816780), Ahmad Hajiloo (13816777), Romina Bayati (13816778), Heshmatollah Asadi (5460002), Amirhossein Nasrollahi (13816782), Hatami, Amirali, Nourmohammadi, Mohammad Javad, Amirhossein Yarahmadi (13816785), Bayati, Romina, Hajiloo, Ahmad   +15 more
core   +1 more source

Characterizing intentions to receive the COVID-19 vaccine among the general population in British Columbia based on their future intentions towards the seasonal influenza vaccine

Vaccine: X, 2022
Introduction: This study assessed the relationship between intention to receive a COVID-19 vaccine and intention to receive a seasonal influenza vaccine, as well as how intention to receive a COVID-19 vaccine has changed during the pandemic.
Bhawna Sharma, C. Sarai Racey, Amy Booth, Arianne Albert, Laurie W. Smith, Anna Gottschlich, David M. Goldfarb, Melanie C.M. Murray, Liisa A.M. Galea, Angela Kaida, Lori A. Brotto, Manish Sadarangani, Gina S. Ogilvie   +12 more
doaj   +1 more source

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

The Lancet, 2020
Background We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome ...
D. Logunov, I. Dolzhikova, O. Zubkova, A. Tukhvatulin, D. Shcheblyakov, A. Dzharullaeva, D. Grousova, A. Erokhova, A. Kovyrshina, A. G. Botikov, F. Izhaeva, O. Popova, T. Ozharovskaya, I. Esmagambetov, I. Favorskaya, D. Zrelkin, Daria V Voronina, D. Shcherbinin, A. Semikhin, Y. Simakova, E. Tokarskaya, N. Lubenets, D. Egorova, M. M. Shmarov, N. Nikitenko, L. Morozova, E. Smolyarchuk, E. V. Kryukov, V. F. Babira, S. Borisevich, B. Naroditsky, A. Gintsburg   +31 more
semanticscholar   +1 more source

The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic

Human Vaccines & Immunotherapeutics, 2022
Background Addressing COVID-19 vaccine hesitancy is key to ending the COVID-19 pandemic. Communication and media environments are potential drivers of vaccine hesitancy.
Hui Ouyang, Xiaohan Ma, Xiang Wu
doaj   +1 more source

COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II

Psychological Medicine, 2020
Background Our aim was to estimate provisional willingness to receive a coronavirus 2019 (COVID-19) vaccine, identify predictive socio-demographic factors, and, principally, determine potential causes in order to guide information provision.
D. Freeman, B. S. Loe, A. Chadwick, Cristian Vaccari, Felicity Waite, L. Rosebrock, Lucy Jenner, Ariane Petit, S. Lewandowsky, S. Vanderslott, Stefania Innocenti, M. Larkin, Alberto Giubilini, Ly-Mee Yu, H. McShane, A. Pollard, S. Lambe   +16 more
semanticscholar   +1 more source